US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist
  • 0.6889
  • +0.0110+1.62%
Close Nov 29 13:00 ET
  • 0.6890
  • +0.0001+0.01%
Post 16:50 ET
71.51MMarket Cap-1497P/E (TTM)

Unicycive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
-29.02%675K
0
0
0
675K
951K
0
Operating revenue
--0
--0
--0
-29.02%675K
--0
--0
--0
--675K
--951K
--0
Cost of revenue
Gross profit
Operating expense
5.27%6.25M
71.24%7.4M
88.72%9.2M
12.87%21.45M
18.55%6.31M
-8.72%5.94M
18.87%4.32M
37.89%4.88M
111.69%19M
93.50%5.33M
Selling and administrative expenses
24.94%3.21M
23.26%2.53M
29.45%2.39M
30.15%8.55M
40.07%2.08M
50.76%2.57M
15.71%2.06M
15.15%1.85M
126.68%6.57M
6.76%1.49M
-General and administrative expense
24.94%3.21M
23.26%2.53M
29.45%2.39M
30.15%8.55M
40.07%2.08M
50.76%2.57M
15.71%2.06M
15.15%1.85M
126.68%6.57M
6.76%1.49M
Research and development costs
-9.70%3.05M
114.73%4.87M
124.85%6.81M
3.75%12.9M
10.23%4.23M
-29.79%3.37M
21.88%2.27M
56.75%3.03M
104.54%12.44M
182.15%3.84M
Operating profit
-5.27%-6.25M
-71.24%-7.4M
-119.04%-9.2M
-15.08%-20.77M
-18.55%-6.31M
-6.91%-5.94M
-18.87%-4.32M
-18.80%-4.2M
-101.09%-18.05M
-93.50%-5.33M
Net non-operating interest income expense
91.87%401K
120.79%446K
2,350.00%49K
8,983.33%533K
4,133.33%121K
7,066.67%209K
202K
2K
99.04%-6K
-3K
Non-operating interest income
83.26%416K
97.44%462K
392.86%69K
--615K
--140K
--227K
--234K
--14K
--0
--0
Non-operating interest expense
-16.67%15K
-50.00%16K
66.67%20K
1,266.67%82K
533.33%19K
500.00%18K
--32K
--12K
-99.04%6K
--3K
Other net income (expense)
25.64%1.75M
5,860.99%16.81M
-13.81%-11.81M
-10.3M
-1.61M
1.4M
282K
-10.38M
Gain on sale of security
25.64%1.75M
5,860.99%16.81M
-13.81%-11.81M
---10.3M
---1.61M
--1.4M
--282K
---10.38M
----
----
Income before tax
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
-69.14%-30.54M
-46.36%-7.8M
22.03%-4.33M
-5.56%-3.84M
-312.07%-14.58M
-80.27%-18.06M
-93.60%-5.33M
Income tax
Net income
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
-69.14%-30.54M
-46.36%-7.8M
22.03%-4.33M
-5.56%-3.84M
-312.07%-14.58M
-80.27%-18.06M
-93.60%-5.33M
Net income continuous Operations
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
-69.14%-30.54M
-46.36%-7.8M
22.03%-4.33M
-5.56%-3.84M
-312.07%-14.58M
-80.27%-18.06M
-93.60%-5.33M
Minority interest income
Net income attributable to the parent company
5.47%-4.1M
356.77%9.86M
-43.83%-20.96M
-69.14%-30.54M
-46.36%-7.8M
22.03%-4.33M
-5.56%-3.84M
-312.07%-14.58M
-80.27%-18.06M
-93.60%-5.33M
Preferred stock dividends
47.10%887K
8.33%208K
867K
0
72K
603K
192K
Other preferred stock dividends
5.93M
0
Net income attributable to common stockholders
7.01%-4.1M
168.52%3.04M
-43.37%-21.17M
-73.95%-31.41M
-46.36%-7.8M
20.73%-4.41M
-22.14%-4.44M
-317.50%-14.77M
-80.27%-18.06M
-93.60%-5.33M
Basic earnings per share
61.54%-0.05
127.59%0.08
37.11%-0.61
-6.67%-1.28
54.29%-0.16
64.86%-0.13
-20.83%-0.29
-304.17%-0.97
-39.53%-1.2
-105.88%-0.35
Diluted earnings per share
61.54%-0.05
48.28%-0.15
37.11%-0.61
-6.67%-1.28
54.29%-0.16
64.86%-0.13
-20.83%-0.29
-304.17%-0.97
-39.53%-1.2
-105.88%-0.35
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000-29.02%675K000675K951K0
Operating revenue --0--0--0-29.02%675K--0--0--0--675K--951K--0
Cost of revenue
Gross profit
Operating expense 5.27%6.25M71.24%7.4M88.72%9.2M12.87%21.45M18.55%6.31M-8.72%5.94M18.87%4.32M37.89%4.88M111.69%19M93.50%5.33M
Selling and administrative expenses 24.94%3.21M23.26%2.53M29.45%2.39M30.15%8.55M40.07%2.08M50.76%2.57M15.71%2.06M15.15%1.85M126.68%6.57M6.76%1.49M
-General and administrative expense 24.94%3.21M23.26%2.53M29.45%2.39M30.15%8.55M40.07%2.08M50.76%2.57M15.71%2.06M15.15%1.85M126.68%6.57M6.76%1.49M
Research and development costs -9.70%3.05M114.73%4.87M124.85%6.81M3.75%12.9M10.23%4.23M-29.79%3.37M21.88%2.27M56.75%3.03M104.54%12.44M182.15%3.84M
Operating profit -5.27%-6.25M-71.24%-7.4M-119.04%-9.2M-15.08%-20.77M-18.55%-6.31M-6.91%-5.94M-18.87%-4.32M-18.80%-4.2M-101.09%-18.05M-93.50%-5.33M
Net non-operating interest income expense 91.87%401K120.79%446K2,350.00%49K8,983.33%533K4,133.33%121K7,066.67%209K202K2K99.04%-6K-3K
Non-operating interest income 83.26%416K97.44%462K392.86%69K--615K--140K--227K--234K--14K--0--0
Non-operating interest expense -16.67%15K-50.00%16K66.67%20K1,266.67%82K533.33%19K500.00%18K--32K--12K-99.04%6K--3K
Other net income (expense) 25.64%1.75M5,860.99%16.81M-13.81%-11.81M-10.3M-1.61M1.4M282K-10.38M
Gain on sale of security 25.64%1.75M5,860.99%16.81M-13.81%-11.81M---10.3M---1.61M--1.4M--282K---10.38M--------
Income before tax 5.47%-4.1M356.77%9.86M-43.83%-20.96M-69.14%-30.54M-46.36%-7.8M22.03%-4.33M-5.56%-3.84M-312.07%-14.58M-80.27%-18.06M-93.60%-5.33M
Income tax
Net income 5.47%-4.1M356.77%9.86M-43.83%-20.96M-69.14%-30.54M-46.36%-7.8M22.03%-4.33M-5.56%-3.84M-312.07%-14.58M-80.27%-18.06M-93.60%-5.33M
Net income continuous Operations 5.47%-4.1M356.77%9.86M-43.83%-20.96M-69.14%-30.54M-46.36%-7.8M22.03%-4.33M-5.56%-3.84M-312.07%-14.58M-80.27%-18.06M-93.60%-5.33M
Minority interest income
Net income attributable to the parent company 5.47%-4.1M356.77%9.86M-43.83%-20.96M-69.14%-30.54M-46.36%-7.8M22.03%-4.33M-5.56%-3.84M-312.07%-14.58M-80.27%-18.06M-93.60%-5.33M
Preferred stock dividends 47.10%887K8.33%208K867K072K603K192K
Other preferred stock dividends 5.93M0
Net income attributable to common stockholders 7.01%-4.1M168.52%3.04M-43.37%-21.17M-73.95%-31.41M-46.36%-7.8M20.73%-4.41M-22.14%-4.44M-317.50%-14.77M-80.27%-18.06M-93.60%-5.33M
Basic earnings per share 61.54%-0.05127.59%0.0837.11%-0.61-6.67%-1.2854.29%-0.1664.86%-0.13-20.83%-0.29-304.17%-0.97-39.53%-1.2-105.88%-0.35
Diluted earnings per share 61.54%-0.0548.28%-0.1537.11%-0.61-6.67%-1.2854.29%-0.1664.86%-0.13-20.83%-0.29-304.17%-0.97-39.53%-1.2-105.88%-0.35
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data